CVRx logo

CVRx

A company that developed Barostim neo, an implantable technology to treat high blood pressure and heart failure

2

Funding Rounds

$142.6m

Money raised

Overview

A company that developed Barostim neo, an implantable technology to treat high blood pressure and heart failure

Funding

Funding series

Funding Series Analysis

The company CVRx has raised a total of $142.6m in funding over 2 rounds.

Key Insights:

  • CVRx Series G round, August 2016: $113m
  • CVRx Series F round: $29.6m
CVRx logo
CVRx Series G round, August 2016 $113m
CVRx logo
CVRx Series F round $29.6m

Industries

CVRx is active in the following industries:
  • Biomedical engineering
  • Neurotechnology
  • Medical device
  • Cardiovascular disease
  • Engineering
  • Neuroscience
  • Technology
  • Biology
  • Biotechnology
  • Cardiology
  • Healthcare
  • Internal medicine
  • Medicine
  • Health technology